Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	23.8	22.35	32.55	45.75	74.59	9.81
Short-Term Investments	27.83	80.4	65.34	-	-	-
Cash & Short-Term Investments	51.63	102.75	97.89	45.75	74.59	9.81
Cash Growth	-49.66%	4.96%	113.99%	-38.67%	660.53%	-58.94%
Prepaid Expenses	2.82	2.07	2.94	2.17	1.32	0.31
Total Current Assets	54.44	104.82	100.83	47.92	75.92	10.12
Property, Plant & Equipment	22.32	35.28	4.47	5.86	4.47	3.42
Long-Term Deferred Charges	-	-	-	-	-	1.1
Other Long-Term Assets	1.99	2.5	4.67	1.09	0.45	0.33
Total Assets	78.76	142.6	109.97	54.87	80.83	14.96
Accounts Payable	2.29	3.13	2.62	3.13	0.92	1.07
Accrued Expenses	3.2	8.14	8.37	3.63	2.83	3.13
Current Portion of Leases	4	5.43	1.55	1.07	0.99	0.9
Current Unearned Revenue	0.61	1.66	1.28	9.79	-	-
Other Current Liabilities	4.86	1.23	0.66	0.63	0.15	0.11
Total Current Liabilities	14.95	19.6	14.47	18.25	4.88	5.21
Long-Term Leases	31.32	21.45	0.67	0.38	1.45	2.43
Long-Term Unearned Revenue	11.86	12.14	14.08	1.93	-	-
Total Liabilities	58.14	53.18	29.21	20.55	6.34	7.64
Common Stock	0.07	0.06	0.03	0.01	0.01	-
Additional Paid-In Capital	414.35	400.69	329.39	227.7	224.36	4.42
Retained Earnings	-393.81	-311.36	-248.68	-193.4	-149.88	-127.76
Comprehensive Income & Other	0.02	0.03	0.01	-	-	-
Total Common Equity	20.62	89.42	80.75	34.32	74.49	-123.34
Shareholders' Equity	20.62	89.42	80.75	34.32	74.49	7.33
Total Liabilities & Equity	78.76	142.6	109.97	54.87	80.83	14.96
Total Debt	35.32	26.88	2.22	1.45	2.44	3.33
Net Cash (Debt)	16.3	75.87	95.68	44.29	72.15	6.48
Net Cash Growth	-83.06%	-20.70%	116.01%	-38.61%	1013.14%	-72.87%
Net Cash Per Share	0.25	1.52	3.16	3.41	8.40	32.07
Filing Date Shares Outstanding	65.46	59.74	31.83	13.01	12.95	0.23
Total Common Shares Outstanding	65.46	57.21	31.83	13.01	12.93	0.23
Working Capital	39.49	85.22	86.36	29.67	71.03	4.91
Book Value Per Share	0.32	1.56	2.54	2.64	5.76	-534.17
Tangible Book Value	20.62	89.42	80.75	34.32	74.49	-123.34
Tangible Book Value Per Share	0.32	1.56	2.54	2.64	5.76	-534.17
Machinery	5.09	3.4	5.35	5.59	3.58	2.02
Construction In Progress	-	-	-	-	0.5	0.14
Leasehold Improvements	0.49	0.46	0.4	2.11	0.32	0.32

Source: S&P Capital IQ. Standard template. Financial Sources.